AstraZeneca PLC is 21.6x more valuable than Ascendis Pharma A/S by market capitalization ($286.27 B vs $13.23 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ASND | AZN |
|---|---|---|
| Market cap | $13.23 B | $286.27 B |
| US-listed rank | #790 | #45 |
| SEC filings | 763 | 1,004 |
AstraZeneca PLC is 21.6x more valuable than Ascendis Pharma A/S by market capitalization ($286.27 B vs $13.23 B).
Full pages: Ascendis Pharma A/S and AstraZeneca PLC, or browse the full rankings.